Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Other Accumulated Expenses (2016 - 2026)

Prothena Corp Public has reported Other Accumulated Expenses over the past 14 years, most recently at $11.8 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 25.61% year-over-year to $11.8 million; the TTM value through Dec 2025 reached $11.8 million, down 25.61%, while the annual FY2025 figure was $11.8 million, 25.61% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $11.8 million at Prothena Corp Public, up from $8.2 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $15.8 million in Q4 2024 and troughed at $4.3 million in Q1 2021.
  • A 5-year average of $10.0 million and a median of $9.5 million in 2021 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 78.73% in 2022 and later tumbled 42.61% in 2025.
  • Year by year, Other Accumulated Expenses stood at $9.8 million in 2021, then increased by 24.0% to $12.2 million in 2022, then grew by 28.71% to $15.7 million in 2023, then increased by 1.16% to $15.8 million in 2024, then dropped by 25.61% to $11.8 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for PRTA at $11.8 million in Q4 2025, $8.2 million in Q3 2025, and $6.4 million in Q2 2025.